Cargando…

The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community

BACKGROUND: In developing the PatientsLikeMe online platform for patients with Multiple Sclerosis (MS), we required a patient-reported assessment of functional status that was easy to complete and identified disability in domains other than walking. Existing measures of functional status were inadeq...

Descripción completa

Detalles Bibliográficos
Autores principales: Wicks, Paul, Vaughan, Timothy E, Massagli, Michael P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502161/
https://www.ncbi.nlm.nih.gov/pubmed/22709981
http://dx.doi.org/10.1186/1477-7525-10-70
_version_ 1782250279481114624
author Wicks, Paul
Vaughan, Timothy E
Massagli, Michael P
author_facet Wicks, Paul
Vaughan, Timothy E
Massagli, Michael P
author_sort Wicks, Paul
collection PubMed
description BACKGROUND: In developing the PatientsLikeMe online platform for patients with Multiple Sclerosis (MS), we required a patient-reported assessment of functional status that was easy to complete and identified disability in domains other than walking. Existing measures of functional status were inadequate, clinician-reported, focused on walking, and burdensome to complete. In response, we developed the Multiple Sclerosis Rating Scale (MSRS). METHODS: We adapted a clinician-rated measure, the Guy’s Neurological Disability Scale, to a self-report scale and deployed it to an online community. As part of our validation process we reviewed discussions between patients, conducted patient cognitive debriefing, and made minor improvements to form a revised scale (MSRS-R) before deploying a cross-sectional survey to patients with relapsing-remitting MS (RRMS) on the PatientsLikeMe platform. The survey included MSRS-R and comparator measures: MSIS-29, PDDS, NARCOMS Performance Scales, PRIMUS, and MSWS-12. RESULTS: In total, 816 RRMS patients responded (19% response rate). The MSRS-R exhibited high internal consistency (Cronbach’s alpha = .86). The MSRS-R walking item was highly correlated with alternative walking measures (PDDS, ρ = .84; MSWS-12, ρ = .83; NARCOMS mobility question, ρ = .86). MSRS-R correlated well with comparison instruments and differentiated between known groups by PDDS disease stage and relapse burden in the past two years. Factor analysis suggested a single factor accounting for 51.5% of variance. CONCLUSIONS: The MSRS-R is a concise measure of MS-related functional disability, and may have advantages for disease measurement over longer and more burdensome instruments that are restricted to a smaller number of domains or measure quality of life. Studies are underway describing the use of the instrument in contexts outside our online platform such as clinical practice or trials. The MSRS-R is released for use under creative commons license.
format Online
Article
Text
id pubmed-3502161
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35021612012-11-21 The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community Wicks, Paul Vaughan, Timothy E Massagli, Michael P Health Qual Life Outcomes Research BACKGROUND: In developing the PatientsLikeMe online platform for patients with Multiple Sclerosis (MS), we required a patient-reported assessment of functional status that was easy to complete and identified disability in domains other than walking. Existing measures of functional status were inadequate, clinician-reported, focused on walking, and burdensome to complete. In response, we developed the Multiple Sclerosis Rating Scale (MSRS). METHODS: We adapted a clinician-rated measure, the Guy’s Neurological Disability Scale, to a self-report scale and deployed it to an online community. As part of our validation process we reviewed discussions between patients, conducted patient cognitive debriefing, and made minor improvements to form a revised scale (MSRS-R) before deploying a cross-sectional survey to patients with relapsing-remitting MS (RRMS) on the PatientsLikeMe platform. The survey included MSRS-R and comparator measures: MSIS-29, PDDS, NARCOMS Performance Scales, PRIMUS, and MSWS-12. RESULTS: In total, 816 RRMS patients responded (19% response rate). The MSRS-R exhibited high internal consistency (Cronbach’s alpha = .86). The MSRS-R walking item was highly correlated with alternative walking measures (PDDS, ρ = .84; MSWS-12, ρ = .83; NARCOMS mobility question, ρ = .86). MSRS-R correlated well with comparison instruments and differentiated between known groups by PDDS disease stage and relapse burden in the past two years. Factor analysis suggested a single factor accounting for 51.5% of variance. CONCLUSIONS: The MSRS-R is a concise measure of MS-related functional disability, and may have advantages for disease measurement over longer and more burdensome instruments that are restricted to a smaller number of domains or measure quality of life. Studies are underway describing the use of the instrument in contexts outside our online platform such as clinical practice or trials. The MSRS-R is released for use under creative commons license. BioMed Central 2012-06-18 /pmc/articles/PMC3502161/ /pubmed/22709981 http://dx.doi.org/10.1186/1477-7525-10-70 Text en Copyright ©2012 Wicks et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wicks, Paul
Vaughan, Timothy E
Massagli, Michael P
The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community
title The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community
title_full The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community
title_fullStr The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community
title_full_unstemmed The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community
title_short The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community
title_sort multiple sclerosis rating scale, revised (msrs-r): development, refinement, and psychometric validation using an online community
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502161/
https://www.ncbi.nlm.nih.gov/pubmed/22709981
http://dx.doi.org/10.1186/1477-7525-10-70
work_keys_str_mv AT wickspaul themultiplesclerosisratingscalerevisedmsrsrdevelopmentrefinementandpsychometricvalidationusinganonlinecommunity
AT vaughantimothye themultiplesclerosisratingscalerevisedmsrsrdevelopmentrefinementandpsychometricvalidationusinganonlinecommunity
AT massaglimichaelp themultiplesclerosisratingscalerevisedmsrsrdevelopmentrefinementandpsychometricvalidationusinganonlinecommunity
AT wickspaul multiplesclerosisratingscalerevisedmsrsrdevelopmentrefinementandpsychometricvalidationusinganonlinecommunity
AT vaughantimothye multiplesclerosisratingscalerevisedmsrsrdevelopmentrefinementandpsychometricvalidationusinganonlinecommunity
AT massaglimichaelp multiplesclerosisratingscalerevisedmsrsrdevelopmentrefinementandpsychometricvalidationusinganonlinecommunity